within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L03A_Immunostimulants.L03AB07_InterferonBeta1a;

model InterferonBeta1a_1
  extends Pharmacolibrary.Drugs.ATC.L.L03AB07_1;

  annotation (Documentation(
info       = "<html><body><table><tr><td>name:</td><td>InterferonBeta1a_1</td></tr><tr><td>ATC code:</td><td>L03AB07_1</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Interferon beta-1a is a recombinant form of human interferon beta, used primarily in the treatment of relapsing forms of multiple sclerosis (MS). It is approved by regulatory agencies such as the FDA and EMA for MS to reduce frequency of relapses and slow progression of physical disability.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics reported for adult MS patients after subcutaneous administration of 44 micrograms three times a week.</p><h4>References</h4><ol><li><p>Zhao, Y, et al., &amp; Butts, CL (2022). Pharmacokinetics/pharmacodynamics by race: Analysis of a peginterferon β-1a phase 1 study. <i>Med (New York, N.Y.)</i> 3(9) 612–621.e3. DOI:<a href=\"https://doi.org/10.1016/j.medj.2022.06.006\">10.1016/j.medj.2022.06.006</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/35853458/\">https://pubmed.ncbi.nlm.nih.gov/35853458</a></p></li><li><p>Hu, X, et al., &amp; Werneburg, B (2016). COMPARE: Pharmacokinetic profiles of subcutaneous peginterferon beta-1a and subcutaneous interferon beta-1a over 2 weeks in healthy subjects. <i>British journal of clinical pharmacology</i> 82(2) 380–388. DOI:<a href=\"https://doi.org/10.1111/bcp.12968\">10.1111/bcp.12968</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27060836/\">https://pubmed.ncbi.nlm.nih.gov/27060836</a></p></li><li><p>Hoy, SM (2015). Peginterferon beta-1a: a review of its use in patients with relapsing-remitting multiple sclerosis. <i>CNS drugs</i> 29(2) 171–179. DOI:<a href=\"https://doi.org/10.1007/s40263-015-0227-1\">10.1007/s40263-015-0227-1</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25666445/\">https://pubmed.ncbi.nlm.nih.gov/25666445</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end InterferonBeta1a_1;
